ASTERDM - Swing Trade Analysis with AI Signals
← Back to ListKey Parameters
⭐ Swing Trade Rating: 3.2
✅ Positive
The stock has demonstrated significant revenue growth in the last quarter, increasing from 58.9 Cr. to 85.3 Cr., indicating strong operational performance. Furthermore, the company exhibits a reasonable debt-to-equity ratio of 0.31, suggesting financial stability.
⚠️ Limitation
Despite positive earnings growth, the stock's high P/E ratio of 217 and PEG ratio of 9.18 suggest overvaluation compared to industry peers and potential future growth expectations. The substantial decrease in FII holdings could signal a lack of investor confidence.
📉 Company Negative News
Recent news indicates a 'Hold' rating from MarketsMojo, suggesting analysts do not anticipate significant upside for the stock at its current price level. This implies limited near-term catalysts or positive developments driving further gains.
📈 Company Positive News
None found
🏭 Industry
The healthcare sector is currently experiencing growth driven by increasing demand for medical services and pharmaceutical products globally. Specifically, Aster DM Healthcare operates within the diversified healthcare segment, encompassing hospitals, clinics, and pharmacies, presenting moderate risk alongside potential rewards.
🧾 Conclusion
Considering its recent performance and valuation, a potential entry point could be around 805 ₹, targeting a profit taking exit at 835 ₹ – 845 ₹ if the stock moves upwards in the next 2-3 weeks. Overall, this stock presents a moderate swing trading opportunity with inherent risks due to its high P/E ratio and recent negative analyst sentiment.